The role of data mining in pharmacovigilance (Q31000827)

28 June 2017

1 reference

title

The role of data mining in pharmacovigilance (English)

1 reference

28 June 2017

0 references

0 references

0 references

2

0 references

Manfred Hauben

series ordinal

1

object named as

Manfred Hauben

1 reference

28 June 2017

Charles M Gerrits

3

1 reference

28 June 2017

Louisa Walsh

series ordinal

4

1 reference

28 June 2017

Eugene P Van Puijenbroek

series ordinal

5

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Drug Safety

28 June 2017

1 reference

28 June 2017

4

1 reference

28 June 2017

5

1 reference

28 June 2017

929-948

1 reference

Principles of signal detection in pharmacovigilance

28 June 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Data mining issues and opportunities for building nursing knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Expecting the unexpected--drug safety, pharmacovigilance, and the prepared mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

A Bayesian neural network method for adverse drug reaction signal generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Use of measures of disproportionality in pharmacovigilance: three Dutch examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

A brief primer on automated signal detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Causal Inference Using Potential Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Different risks for NSAID-induced anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Pharmacovigilance in the 21st century: new systematic tools for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Drug-induced pancreatitis: lessons in data mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Case reports of dobutamine-induced myoclonia in severe renal failure: potential of emerging pharmacovigilance technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Early postmarketing drug safety surveillance: data mining points to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Comparison of data mining methodologies using Japanese spontaneous reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

The effect of backgrounds in safety analysis: the impact of comparison cases on what you see

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

Using MedDRA: implications for risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.929

21 January 2018

Identifiers

DOI

10.1517/14740338.4.5.929

1 reference

28 June 2017

1 reference